Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes - Test2 - elhamkhani - TriplyDB

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

http://www.wikidata.org/entity/Q24614628

about

A highly conserved neutralizing epitope on group 2 influenza A viruses B Cells and Functional Antibody Responses to Combat Influenza Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies Universal immunity to influenza must outwit immune evasion Influenza virus hemagglutinin stalk-based antibodies and vaccines Towards a universal influenza vaccine: volunteer virus challenge studies in quarantine to speed the development and subsequent licensing Advancements in the development of subunit influenza vaccines Broadly neutralizing antibodies against influenza virus and prospects for universal therapies Structural vaccinology: structure-based design of influenza A virus hemagglutinin subtype-specific subunit vaccines Structural and Functional Basis for Inhibition of Erythrocyte Invasion by Antibodies that Target Plasmodium falciparum EBA-175 Genome-wide analyses reveal a highly conserved Dengue virus envelope peptide which is critical for virus viability and antigenic in humans Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodies Inhibition of influenza A virus infection in vitro by peptides designed in silico H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.Immunization of rabbits with synthetic peptides derived from a highly conserved β-sheet epitope region underneath the receptor binding site of influenza A virus Production and stabilization of the trimeric influenza hemagglutinin stem domain for potentially broadly protective influenza vaccines Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.New vaccines against influenza virus.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Universal influenza vaccines, a dream to be realized soon.Continuing challenges in influenza.Advances in influenza vaccination.In silico structural homology modelling and docking for assessment of pandemic potential of a novel H7N9 influenza virus and its ability to be neutralized by existing anti-hemagglutinin antibodies.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Different arms of the adaptive immune system induced by a combination vaccine work in concert to provide enhanced clearance of influenza.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Novel universal influenza virus vaccine approaches Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.Screening of random peptide library of hemagglutinin from pandemic 2009 A(H1N1) influenza virus reveals unexpected antigenically important regions.A reassortment-incompetent live attenuated influenza virus vaccine for protection against pandemic virus strains.Cross-neutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2.Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine Annual vaccination against influenza virus hampers development of virus-specific CD8⁺ T cell immunity in children

P2860

Q24630467-8A3D786B-FCFF-4A93-9581-15C62FF73C15 Q26801639-FC18E44B-FF91-4F2C-842D-CD8A9D0316E2 Q26823492-2F868E0B-03D2-4C6B-9D2A-B32326B6EA44 Q26991896-C9BB8493-7B6F-4752-8CD2-F4C0CE44165C Q27001190-EA03C471-21E3-4DCC-A2E4-7AA0CEED3554 Q27003874-D4F890CB-D421-43C3-97E8-A84CE13B4791 Q27010100-2DFC11F4-B533-4864-A8CB-1FF6A1401FF6 Q27010503-A9CD0545-DC81-4893-90CE-7D8E2D4DE431 Q27676658-AE786275-516B-4263-87DE-243DAD41E74F Q27678372-C856ADA6-2202-493C-9489-C0927438ED06 Q27682470-01B341C6-91C2-456B-9042-81E6A7242DC3 Q28396120-D60C0C2C-7794-406C-B6E5-A806EA298379 Q28534343-D5E3CEBC-7658-4C67-BD75-3AB875D9EF81 Q28743596-AB881662-F18C-4DFC-ABD9-AB3B59A56E70 Q30205195-050AB89A-ADF7-46F1-8E96-44D28D6B63F4 Q30209769-7BF1BCB7-04DE-4944-A834-9A15E6BA1D1F Q30223058-52B5309E-58F1-4315-BA9F-DD925495F40A Q30355629-2007153F-30FE-402D-BD83-216EAB2F826A Q30356933-8F14473A-72B8-4388-872F-ACE73B0E33BD Q30357665-BE0DE38A-E196-42D4-9FE3-4C8D9AF02BE6 Q30357932-41B23D00-4EB7-482F-A505-2E4BC8519BB8 Q30358388-99A8FFE2-254B-4AB7-903F-F0A99BF60ADD Q30361950-79C167E5-B2C5-44F7-96C1-4F732981D89E Q30363190-D11350DA-29A8-4266-BCA3-C52E3AABC24A Q30364315-896748BD-65E4-4842-8BD7-0116BA083157 Q30364943-2A2A25FD-3732-4C52-A981-007046454B48 Q30368005-6017BB36-8194-47BB-829E-549A2C6FB722 Q30369956-7AC60BCC-2C61-472F-A7AD-E76636BA9689 Q30372274-28C637BC-4CFA-4081-A776-BF2398A2B146 Q30385071-8B87ED79-FE62-4858-A1D3-7464C8A8F915 Q30387031-B9DE0986-1625-470C-98A4-B460F5FAD4CC Q30388004-ED872879-BC9C-4A64-8C15-D9C16FA86EEA Q30388011-9F944ACF-2D41-427B-B70E-83029845C424 Q30398516-77F63761-3D73-47C6-813C-697FD71E154C Q30400817-921F58E0-B40B-48F7-B129-68177D9BF65A Q30401148-1D91E212-F8A3-43A5-9F59-A39ADB54662E Q30402334-BCBDA970-BF6D-4A0E-B70C-4C6468E20761 Q30404095-A85C6914-285A-4D0C-AF8F-981A7608E7B5 Q30406344-0289A432-A3AE-4EAD-9365-EAE4CF2B851C Q30406576-AF84BC41-F055-45C4-B89F-B24D4F5F82DC

P2860

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

http://www.wikidata.org/entity/Q24614628

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@ast

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@en

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@nl

type

label

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@ast

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@en

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@nl

prefLabel

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@ast

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@en

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@nl

P1433

Q24614628-CD4880C5-B2A2-4093-BFD0-71CE79177D22

P1476

Q24614628-61E74FF1-9DA8-469D-AB5C-0FDD9814BB5B

P2093

Q24614628-3B3F33C0-0377-4EE2-895F-41ED70AE0D3A

Q24614628-6840F209-C368-4DA9-96F2-E8DA3AE23A90

Q24614628-A994564D-F5B4-436F-8E9D-E0507D2ACA3B

Q24614628-C5B81959-98BE-43A1-8203-5CAD264CDF38

Q24614628-F6F0BD0B-0123-4E42-90C3-2E3FE2E1E39C

P2860

Q24614628-097CC19D-0BCA-4207-9D61-64E9B2738747

Q24614628-0A49B064-F232-4CE3-A8BF-3CE4EA3127F1

Q24614628-1813167C-561E-43F4-9DB8-E02C93857BAB

Q24614628-2CB758C0-031B-4B10-9C15-A8CECA1B2248

Q24614628-3FC8D6AD-BDB9-4973-96CB-811C802EFA6D

Q24614628-43AC4A02-CF48-4831-9BB8-6EE24D748988

Q24614628-4FF24265-C5C8-45B1-9D69-094A351345E6

Q24614628-5708C2E1-A383-45CF-B1C3-186AB96403BD

Q24614628-91135F99-4430-4B54-8E76-C3EDF43BA2F0

Q24614628-94DAA220-5B09-4693-A9D5-AB916F8832D0

P304

Q24614628-DF681897-6149-4162-B8DF-1B2332DF400A

P31

Q24614628-24CA9B67-D12D-4CC1-8A8F-1AC7CDACEB9F

P3181

Q24614628-0546D327-8D6A-4134-8A98-14E5EEBED457

P356

Q24614628-D6D429DC-EDDC-4B9C-ADF0-57CD5A8FEA61

P407

Q24614628-496E8881-3E49-422D-A63B-7FA06CDDF20F

P433

Q24614628-558D20B2-813F-415A-B80F-F672E16534D1

P478

Q24614628-CF10199A-DF3C-4036-87F3-821F690F4E30

P50

Q24614628-0AFCA905-9803-4BFD-BE99-C25FB4329C04

Q24614628-20E319E9-8863-4548-9C99-6DB6A66CC186

Q24614628-3A617AF4-230F-4E55-9607-BAC37047F289

Q24614628-4E472CCB-EF0E-46C2-9B7F-3A9A6C5014E1

Q24614628-56A628FC-10C6-4CC7-89D7-B1733A338632

P577

Q24614628-D218D788-7A08-4F88-AEC9-23B76331411B

P5875

Q24614628-A18A3DFE-6F4F-438D-AFAD-FF8219C6A42C

P698

Q24614628-926D24B1-A071-482C-8987-7892BE44CA2A

P921

Q24614628-4EDEEE9A-9979-4E2E-A45A-3A11F56E1B2F

P932

Q24614628-98630A91-D5FB-4BFB-B27B-9C45D18F4DCA

P3181

P356

PNAS.1013387107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Vaccination with a synthetic p ...... gainst distinct viral subtypes

@en

P2093

Lily Ngai

http://www.w3.org/2001/XMLSchema#string

Natalie Pica

http://www.w3.org/2001/XMLSchema#string

Rong Hai

http://www.w3.org/2001/XMLSchema#string

Taia T Wang

http://www.w3.org/2001/XMLSchema#string

Thomas M Moran

http://www.w3.org/2001/XMLSchema#string

P2860

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza

Antibody recognition of a highly conserved influenza virus epitope

N- and C-terminal residues combine in the fusion-pH influenza hemagglutinin HA(2) subunit to form an N cap that terminates the triple-stranded coiled coil

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

P304

18979-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1382098

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1013387107

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Adolfo García-Sastre

Damian C Ekiert

Ian Andrew Wilson

P577

2010-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47459260

http://www.w3.org/2001/XMLSchema#string

P698

20956293

http://www.w3.org/2001/XMLSchema#string

P921

P932

2973924

http://www.w3.org/2001/XMLSchema#string